Advantage Investment Management’s iShares Emerging Markets Dividend ETF DVYE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$28K Hold
755
0.02% 452
2019
Q2
$31K Sell
755
-132
-15% -$5.29K 0.02% 441
2019
Q1
$36K Sell
887
-125
-12% -$5.06K 0.03% 413
2018
Q4
$38K Sell
1,012
-551
-35% -$21K 0.03% 384
2018
Q3
$61K Sell
1,563
-201
-11% -$7.99K 0.04% 355
2018
Q2
$69K Sell
1,764
-506
-22% -$20.9K 0.05% 315
2018
Q1
$98K Sell
2,270
-2,045
-47% -$89.7K 0.04% 251
2017
Q4
$181K Buy
4,315
+1,436
+50% +$59.6K 0.06% 193
2017
Q3
$119K Buy
2,879
+906
+46% +$38K 0.04% 226
2017
Q2
$79K Buy
1,973
+1,353
+218% +$54.4K 0.03% 276
2017
Q1
$25K Buy
+620
New +$23.7K 0.01% 501

Other funds holding DVYE

Advantage Investment Management's DVYE Position: Q3 2019 in Review

Advantage Investment Management held its iShares Emerging Markets Dividend ETF (DVYE) position steady in Q3 2019 at 755 shares worth $28K. The position accounts for 0.02% of the portfolio, ranked #452.

Advantage Investment Management first reported a position in DVYE in Q1 2017 and has held it in 11 quarters since. The position peaked at $181K in Q4 2017. 114 funds tracked by Wall St. Rank hold DVYE as of Q3 2019.

  • Advantage Investment Management held 755 shares of iShares Emerging Markets Dividend ETF worth $28K as of Q3 2019.
  • Advantage Investment Management left its iShares Emerging Markets Dividend ETF share count unchanged in Q3 2019.
  • iShares Emerging Markets Dividend ETF made up 0.02% of Advantage Investment Management's portfolio in Q3 2019, its #452 holding.
  • Advantage Investment Management first reported a position in iShares Emerging Markets Dividend ETF in Q1 2017 and has held it in 11 quarters since.
  • Advantage Investment Management's iShares Emerging Markets Dividend ETF position peaked at $181K in Q4 2017.
  • 114 funds tracked by Wall St. Rank held iShares Emerging Markets Dividend ETF as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.